---
title: "First patient enrolled in RECOVER-AV trial of AlphaVac F18 system for treatment of acute PE"
date: "2025-06-24T08:58:53.000Z"
publishedDate: "24 juin 2025"
summary: "AngioDynamics has announced the first patient has been enrolled in the RECOVER-AV clinical trial, a prospective, multicentre, international, single-arm study evaluating the AlphaVac multipurpose mechanical aspiration (MMA) F1885 system in the treatment of acute, intermediate-risk pulmonary embolism (PE). The study follows the US Food and Drug Administration (FDA) 510(k) clearance of the AlphaVac F1885 system [&#8230;] The post First patient enrolled in RECOVER-AV trial of AlphaVac F18 system for treatment of acute PE appeared first on Interventional News ."
importance: ""
sourceUrl: "https://interventionalnews.com/first-patient-enrolled-in-recover-av-trial-of-alphavac-f18-system-for-treatment-of-acute-pe/"
tags: ["France", "Actualité", "Interventional News — Latest"]
permalink: "/papers/2025-06-24-first-patient-enrolled-in-recover-av-trial-of-alphavac-f18-system-for-treatment-of-acute-pe"
imageUrl: "https://interventionalnews.com/wp-content/uploads/sites/13/2025/06/AngioDynamics-AlphaVac-featured.png"
imageCredit: "Image de l’article — droits possiblement réservés — https://interventionalnews.com/first-patient-enrolled-in-recover-av-trial-of-alphavac-f18-system-for-treatment-of-acute-pe/"
---

![First patient enrolled in RECOVER-AV trial of AlphaVac F18 system for treatment of acute PE](https://interventionalnews.com/wp-content/uploads/sites/13/2025/06/AngioDynamics-AlphaVac-featured.png)

*Crédit image : Image de l’article — droits possiblement réservés — https://interventionalnews.com/first-patient-enrolled-in-recover-av-trial-of-alphavac-f18-system-for-treatment-of-acute-pe/*

## L’essentiel

AngioDynamics has announced the first patient has been enrolled in the RECOVER-AV clinical trial, a prospective, multicentre, international, single-arm study evaluating the AlphaVac multipurpose mechanical aspiration (MMA) F1885 system in the treatment of acute, intermediate-risk pulmonary embolism (PE). The study follows the US Food and Drug Administration (FDA) 510(k) clearance of the AlphaVac F1885 system [&#8230;] The post First patient enrolled in RECOVER-AV trial of AlphaVac F18 system for treatment of acute PE appeared first on Interventional News .

## Lien source

https://interventionalnews.com/first-patient-enrolled-in-recover-av-trial-of-alphavac-f18-system-for-treatment-of-acute-pe/
